Abstract
In this study, 127 sputum/tracheal aspirate specimens were evaluated by a laboratory-developed real-time RT-PCR method and Fusion SARS-CoV-2 assay. These specimens were collected from the patients who have nasopharyngeal swab (NPS) samples being used for SARS-CoV-2 detection previously or simultaneously. The overall agreement was 96% between the lower respiratory tract (LRT) and NPS samples, suggesting that LRT specimens could be an option for patients who develop a productive cough or those receiving invasive mechanical ventilation.
| Original language | English (US) |
|---|---|
| Article number | 115228 |
| Journal | Diagnostic Microbiology and Infectious Disease |
| Volume | 99 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2021 |
Keywords
- COVID-19
- Lower respiratory tract
- Nasopharyngeal swab sample
- SARS-CoV-2
- Sputum
- Tracheal aspirate
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Analysis of sputum/tracheal aspirate and nasopharyngeal samples for SARS-CoV-2 detection by laboratory-developed test and Panther Fusion system'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS